Reta-Peptide
PT-141
Finnrick tested 4 samples of PT-141 (Bremelanotide) from Reta-Peptide between 31 Aug 2025 and 29 Dec 2025. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Reta-Peptide
PT-141
Tested 4 Samples
Last test 29 Dec 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other PT-141 tests from top-rated vendors:
All PT-141 tests from Reta-Peptide
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
29 Dec 2025
First
31 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 29 Dec 2025 | View | 10mg | 10.7mg | +7.0% | 99.95% | (no batch ID) | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 25 Nov 2025 | View | 10mg | 8.47mg | -15.3% | 99.45% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 17 Nov 2025 | View | 10mg | 10.2mg | +2.0% | 99.94% | Oct 2, 2025 | No Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 31 Aug 2025 | View | 10mg | 10.1mg | +1.0% | 99.94% | (no batch ID) | Purple Label / Silver Crimp / Blue Cap | Lab E | Public | |